Enhancement of Bioavailability and Pharmacodynamic Effects of Thymoquinone Via Nanostructured Lipid Carrier (NLC) Formulation.
about
Phytobioactive compound-based nanodelivery systems for the treatment of type 2 diabetes mellitus - current status.Novel diindolylmethane derivatives based NLC formulations to improve the oral bioavailability and anticancer effects in triple negative breast cancer.Thymoquinone as a Potential Adjuvant Therapy for Cancer Treatment: Evidence from Preclinical Studies.Thymoquinone ameliorates diabetic phenotype in Diet-Induced Obesity mice via activation of SIRT-1-dependent pathways.Atorvastatin-loaded nanostructured lipid carriers (NLCs): strategy to overcome oral delivery drawbacks.Therapeutic Potential of Thymoquinone in Glioblastoma Treatment: Targeting Major Gliomagenesis Signaling Pathways.Neuropharmacological Potential and Delivery Prospects of Thymoquinone for Neurological Disorders.Pharmaceutical Dispersion Techniques for Dissolution and Bioavailability Enhancement of Poorly Water-Soluble DrugsProtective Roles of Thymoquinone Nanoformulations: Potential Nanonutraceuticals in Human Diseases
P2860
Q37643472-BBCD4D6C-7F5B-4952-B521-FAE0245C55EFQ38748639-8107F09C-18D8-45DF-831A-55E378FDBB3BQ39403430-59883222-C6C6-47CB-B573-4910545D8A90Q42364332-84EA25A7-C7F5-4508-89B5-153703BA2C34Q48273811-3267B896-7F97-45A2-BDE5-A23B4380476FQ52590668-0DA1EB83-0268-4BDC-A13C-98F143A6D7DCQ55395083-F0E7D178-51A3-4046-B5E0-31BF4548645DQ58032213-77C8416E-38D0-4639-A5DA-5E13E33483D0Q58696844-AEF26395-EC6F-4F96-9D61-BD04A4F3AFF0
P2860
Enhancement of Bioavailability and Pharmacodynamic Effects of Thymoquinone Via Nanostructured Lipid Carrier (NLC) Formulation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Enhancement of Bioavailability ...... pid Carrier (NLC) Formulation.
@en
Enhancement of Bioavailability ...... a Nanostructured Lipid Carrier
@nl
type
label
Enhancement of Bioavailability ...... pid Carrier (NLC) Formulation.
@en
Enhancement of Bioavailability ...... a Nanostructured Lipid Carrier
@nl
prefLabel
Enhancement of Bioavailability ...... pid Carrier (NLC) Formulation.
@en
Enhancement of Bioavailability ...... a Nanostructured Lipid Carrier
@nl
P2093
P50
P1433
P1476
Enhancement of Bioavailability ...... pid Carrier (NLC) Formulation.
@en
P2093
Abdelaziz E Abdelaziz
Ahmed Samy
Ayman Salama
Mohamed A Raslan
Ragab A Said
P2888
P304
P356
10.1208/S12249-015-0391-0
P407
P577
2015-08-25T00:00:00Z
P6179
1031232753